Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Change in Inventory: 2020-2025

Historic Change in Inventory for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to -$1.3 million.

  • GeneDx Holdings' Change in Inventory fell 379.25% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $526,000, marking a year-over-year decrease of 71.38%. This contributed to the annual value of $2.6 million for FY2024, which is 365.13% up from last year.
  • As of Q3 2025, GeneDx Holdings' Change in Inventory stood at -$1.3 million, which was down 112.10% from -$628,000 recorded in Q2 2025.
  • GeneDx Holdings' Change in Inventory's 5-year high stood at $9.8 million during Q1 2021, with a 5-year trough of -$7.6 million in Q4 2022.
  • Its 3-year average for Change in Inventory is $152,909, with a median of -$293,000 in 2023.
  • Per our database at Business Quant, GeneDx Holdings' Change in Inventory spiked by 392.12% in 2023 and then slumped by 379.25% in 2025.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Change in Inventory stood at $3.3 million in 2021, then tumbled by 330.67% to -$7.6 million in 2022, then spiked by 96.14% to -$293,000 in 2023, then surged by 254.95% to $454,000 in 2024, then slumped by 379.25% to -$1.3 million in 2025.
  • Its Change in Inventory was -$1.3 million in Q3 2025, compared to -$628,000 in Q2 2025 and $2.0 million in Q1 2025.